hero
hero
hero
What is (gMG)?

generalizedMYASTHENIAGRAVIS

Myasthenia Gravis is a rare, chronic autoimmune neuromuscular disease.1-4 That targets the neuromuscular junction.1

It is characterized by fluctuating and fatigable skeletal muscle weakness.1-4 gMG can affect many muscle groups, including ocular, bulbar, limb, axial and respiratory muscles.1-4

Know More

Patient Classes3

Class I
Any ocular muscle weakness; may have weakness of eye closure; all other muscle strength is normal
Class II
Mild weakness, affecting muscles other than the ocular muscles; may also have ocular muscle weakness of any severity
Class III
Moderate weakness, affecting muscles other than the ocular muscles; may also have ocular muscle weakness of any severity
Class IV
Severe weakness, affecting muscles other than the ocular muscles; may also have ocular muscle weakness of any severity
Class V
Intubation, with or without mechanical ventilation, except when employed during routine post-operative management
ellipse

Levels of MG disease control5

  • Full disease control

    No disease activity,no residual symptoms

  • Full disease controlwith no detectable disease activity

    Minimal residualsymptoms with stability, incomplete remission

  • Incomplete diseasecontrol with disease activity

    Instability, deterioration, fluctuation with residual symptoms, continuous new or developing symptoms, +/- fluctuations. +/- crises

  • No disease control with high disease activity, including refractory MG

    Continuous symptoms with or without crises or deteriorations, resistance to therapy

True stories of Snowflake warriors

snowflake
Stay Tuned
Watch More videos
mglis
Stay Tuned
Know More

References:

  • 1. Conti-Fine BM et al. J Clin Invest 2006;116:2843-54.
  • 2. Mantegazza R et al. Neuropsychiatr Dis Treat 2011;7:151-60.
  • 3. Thanvi BR et al. Postgrad Med J 2004;80:690-700.
  • 4. Juel VC et al. Orphanet J Rare Dis 2007;2:44.
  • 5. Wiendl H et al.. Guidelines for the management of myasthenic syndromes. Therap Adv Neurol Disord 2023 .

SA-11769

Preparation date: 7/7/2026

Expiry date: 7/7/2028